WBA241213C16500
- 0.00
- 0.000.00%
Walgreens Boots Alliance Newsroom
Walgreens Launches Inaugural Patient Advisory Board to Advance Access and Representation in Clinical Research
Here's Why Walgreens Boots Alliance (WBA) Fell More Than Broader Market
5 Merger and Acquisition Targets to Buy Before Trump Takes Over
Thursday Ends in Index Declines | Wall Street Today
The Fed's Expected Rate Cut Is Giving Stock Traders Cover in a Choppy Market
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
Nearly a Third of Americans Worry About Missing a Holiday Event Due to Illness
Wall Street's Most Accurate Analysts Weigh In On 3 Risk Off Care Stocks With Over 5% Dividend Yields
Walgreens Boots Alliance Options Spot-On: On December 11th, 125.6K Contracts Were Traded, With 1.05 Million Open Interest
Walgreens Boots' Potential Take-Private Deal Expected to Face 'Many Challenges,' Deutsche Bank Says
Walgreens Drops as Analysts Skeptical Over Potential Sale
CVS Might Just Be the Last Drugstore Stock. Should It Be Broken Up? -- Barrons.com
CVS Might Just Be the Last Drugstore Stock. Should It Be Broken Up?
Walgreens Shares Dip Amid Acquisition Skepticism
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Raymond James Maintains Walgreens Boots Alliance(WBA.US) With Hold Rating
Daily short sale tracking: Walgreens Boots Alliance's short volume increased by 20 million, with a short sale ratio of 23%
TD Cowen Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Maintains Target Price $14
Update: Ohio Supreme Court Rules in Favor of Pharmacies in Opioid Crisis Case
A Quick Look at Today's Ratings for Walgreens Boots Alliance(WBA.US), With a Forecast Between $7 to $14